earnings
confidence high
sentiment positive
materiality 0.60
Aspira Q1 revenue up 5.9% to $2.28M; gross margin 68.5%, cash burn reduced 30%
Aspira Women's Health Inc.
2025-Q1 EPS reported
-$0.09
- Revenue $2.28M vs $2.15M YoY (+5.9%), driven by select price increases and 94% jump in sales per FTE.
- Gross profit $1.6M (+28.5%); gross margin improved to 68.5% from 56.4% due to one-time accrual reduction and OvaWatch profitability.
- Operating expenses fell 19% to $4.8M (vs $5.9M); operating cash burn reduced 30% to $3.1M.
- Cash on hand rose to $3.3M from $1.8M; current liabilities decreased 30% to $3.8M.
- CEO Mike Buhle cited early traction under new leadership; ENDOInform R&D updates expected by end of 2025.